Viewing Study NCT00655551


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-02-25 @ 7:22 PM
Study NCT ID: NCT00655551
Status: COMPLETED
Last Update Posted: 2018-07-17
First Post: 2008-03-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
Sponsor: UCB BIOSCIENCES, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-04
Start Date Type: None
Primary Completion Date: 2009-09
Primary Completion Date Type: ACTUAL
Completion Date: 2009-09
Completion Date Type: ACTUAL
First Submit Date: 2008-03-26
First Submit QC Date: None
Study First Post Date: 2008-04-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-09-23
Results First Submit QC Date: None
Results First Post Date: 2010-10-20
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-06-20
Last Update Post Date: 2018-07-17
Last Update Post Date Type: ACTUAL